CoChat

Acute and Life-threatening Complications in Cushing Syndrome: Prevalence, Predictors, and Mortality

Open access
Schernthaner-Reiter, Marie Helene, Siess, Christina, Micko, Alexander, Zauner, Christian, Wolfsberger, Stefan, Scheuba, Christian, Riss, Philipp, Knosp, Engelbert, Kautzky-Willer, Alexandra, Luger, Anton, Vila, Greisa · 2021 · The Journal of Clinical Endocrinology & Metabolism
Cited by 50

The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.

Abstract

Context: Cushing syndrome (CS) results in significant morbidity and mortality. Objective: To study acute and life-threatening complications in patients with active CS. Methods: We performed a retrospective cohort study using inpatient and outpatient records of patients with CS in a tertiary center. A total of 242 patients with CS were included, including 213 with benign CS (pituitary n = 101, adrenal n = 99, ectopic n = 13), and 29 with malignant disease. We collected acute complications necessitating hospitalization, from appearance of first symptoms of hypercortisolism until 1 year after biochemical remission. Mortality data were obtained from the national registry. Baseline factors relating to and predicting acute complications were tested using uni- and multivariate analysis. Results: The prevalence of acute complications was 62% in patients with benign pituitary CS, 40% in patients with benign adrenal CS, and 100% in patients with ectopic CS. Complications observed in patients with benign CS included infections (25%), thromboembolic events (17%), hypokalemia (13%), hypertensive crises (9%), cardiac arrhythmias (5%), and acute coronary events (3%). Among these patients, 23% had already been hospitalized for acute complications before CS was suspected, and half of complications occurred after the first surgery. Glycated hemoglobin (HbA1c) and 24-hour urinary free cortisol positively correlated with the number of acute complications per patient. Patients with malignant disease had significantly higher rates of acute complications. Mortality during the observation period was 2.8% and 59% in benign and malignant CS, respectively. Conclusions: This analysis highlights the whole spectrum of acute and life-threatening complications in CS, and their high prevalence even before disease diagnosis and after successful surgery.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1210/clinem/dgab058

Cites

13 of 13 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 17

  1. Pivonello, 2016, Complications of Cushing’s syndrome: state of the art, Lancet Diabetes Endocrinol., 4, 611, 10.1016/S2213-8587(16)00086-3 · DOI · Paper page
  2. Javanmard, 2018, Mortality in Patients with Endogenous Cushing’s Syndrome, Endocrinol Metab Clin North Am., 47, 313, 10.1016/j.ecl.2018.02.005 · DOI · Paper page
  3. Valassi, 2019, High mortality within 90 days of diagnosis in patients with Cushing’s syndrome: results from the ERCUSYN registry, Eur J Endocrinol., 181, 461, 10.1530/EJE-19-0464 · DOI · Paper page
  4. Hasenmajer, 2020, The Immune System in Cushing’s Syndrome, Trends Endocrinol Metab., 31, 655, 10.1016/j.tem.2020.04.004 · DOI · Paper page
  5. Coelho, 2015, Adverse effects of glucocorticoids: coagulopathy, Eur J Endocrinol., 173, M11, 10.1530/EJE-15-0198 · DOI
  6. Suarez, 2020, Hypercoagulability in Cushing syndrome, prevalence of thrombotic events: a large, single-center, retrospective study, J Endocr Soc., 4, bvz033, 10.1210/jendso/bvz033 · DOI · Paper page
  7. Isidori, 2015, The hypertension of Cushing’s syndrome: controversies in the pathophysiology and focus on cardiovascular complications, J Hypertens., 33, 44, 10.1097/HJH.0000000000000415 · DOI · Paper page
  8. Valassi, 2018, Preoperative medical treatment in Cushing’s syndrome: frequency of use and its impact on postoperative assessment: data from ERCUSYN, Eur J Endocrinol., 178, 399, 10.1530/EJE-17-0997 · DOI · Paper page
  9. Swearingen, 1999, Long-term mortality after transsphenoidal surgery for Cushing disease, Ann Intern Med., 130, 821, 10.7326/0003-4819-130-10-199905180-00015 · DOI · Paper page
  10. Broersen, 2019, The incidence of adrenal crisis in the postoperative period of HPA axis insufficiency after surgical treatment for Cushing’s syndrome, Eur J Endocrinol., 181, 201, 10.1530/EJE-19-0202 · DOI
  11. Sarlis, 2000, Cortisolemic indices predict severe infections in Cushing syndrome due to ectopic production of adrenocorticotropin, J Clin Endocrinol Metab., 85, 42
  12. van Halem, 2017, Characteristics and Mortality of Pneumocystis Pneumonia in Patients With Cushing’s Syndrome: A Plea for Timely Initiation of Chemoprophylaxis, Open Forum Infect Dis., 4, ofx002, 10.1093/ofid/ofx002 · DOI
  13. Papakokkinou, 2020, Excess morbidity persists in patients with Cushing’s disease during long-term remission: a swedish nationwide study, J Clin Endocrinol Metab, 105, 10.1210/clinem/dgaa291 · DOI · Paper page
  14. Stewart, 1995, 11 beta-Hydroxysteroid dehydrogenase activity in Cushing’s syndrome: explaining the mineralocorticoid excess state of the ectopic adrenocorticotropin syndrome, J Clin Endocrinol Metab., 80, 3617
  15. Ilias, 2005, Cushing’s syndrome due to ectopic corticotropin secretion: twenty years’ experience at the National Institutes of Health, J Clin Endocrinol Metab., 90, 4955, 10.1210/jc.2004-2527 · DOI · Paper page
  16. Guarnotta, 2017, The degree of urinary hypercortisolism is not correlated with the severity of Cushing’s syndrome, Endocrine., 55, 564, 10.1007/s12020-016-0914-9 · DOI
  17. Davi’, 2017, Prognostic factors in ectopic Cushing’s syndrome due to neuroendocrine tumors: a multicenter study, Eur J Endocrinol., 176, 453, 10.1530/EJE-16-0809 · DOI

Cited by

See all 50

Metadata

Authors
Schernthaner-Reiter, M. H., Siess, C., Micko, A., Zauner, C., Wolfsberger, S., Scheuba, C., Riss, P., Knosp, E., Kautzky-Willer, A., Luger, A., & Vila, G.
Venue
The Journal of Clinical Endocrinology & Metabolism
Published
2021-01-31
Volume
106
Issue
5
Pages
e2035-e2046
ISSN
  • 0021-972X (ISSN-L)
  • 1945-7197
OpenAlex
W3128971382
Cited by
50
References
13
FWCI
4.21
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.